Results 181 to 190 of about 12,042,484 (342)
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai+4 more
wiley +1 more source
Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna+4 more
wiley +1 more source
Cardiac troponin T and I: back to basics. [PDF]
Mingels AM, Mills NL, Mueller C.
europepmc +1 more source
Troponin‐T: improved diagnostic assessment of myocardial damage in childhood [PDF]
FF Immer+5 more
openalex +1 more source
Use of cardiac troponin t rapid assay in the diagnosis of a myocardial injury secondary to electrical cardioversion [PDF]
Luis Garré+9 more
openalex +1 more source
Abstract Aims Hypertrophic cardiomyopathy (HCM) is a rare genetic heart disease characterized by a limited patient population and scarce research and treatment resources. This study aimed to identify HCM‐associated proteins by integrating cardiac tissue data from the Gene Expression Omnibus (GEO) database with the latest protein quantitative trait ...
Bo Li, Xu Zhao, Yan Ding, Yi Zhang
wiley +1 more source
Plasma troponin T reflects lower motor neuron involvement on electromyography in amyotrophic lateral sclerosis. [PDF]
Chamoun S+15 more
europepmc +1 more source
Early serum cardiac troponin I and T concentrations after successful thrombolysis for acute myocardial infarction [PDF]
Fred S. Apple+2 more
openalex +1 more source
Clinical characteristics and long‐term outcomes in patients with apical hypertrophic cardiomyopathy
Abstract Aims As a special type of hypertrophic cardiomyopathy (HCM), apical HCM (ApHCM) has different clinical characteristics while its nature history and prognosis are not well recognized. We aimed to describe the characteristics and outcomes of ApHCM and identify predictors of adverse outcomes.
Meng Guo+3 more
wiley +1 more source